BioPharma

10 January, 2025 | Friday | News

Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development

In an exclusive interview with BioPharma APAC, Heather Hargett, Head of Cell Biology Reagents & Tools at MilliporeSigma ( Merck KGaA, Darmstadt, Germany), sheds light on the transformative potential of Merc...

Lab

10 January, 2025 | Friday | News

NEC and Biomy Partner to Advance AI-Powered Digital Pathology for Precision Cancer Care

NEC Corporation (NEC; TSE: 6701) and Biomy, Inc. (Biomy) have signed a Memorandum of Understanding (MoU) to form a joint marketing partnership aimed at advancing artificial intelligence and deep learning (AI/DL...

BioTech

08 January, 2025 | Wednesday | News

GenScript Partners with PSCI to Drive Sustainable and Ethical Transformation in Global Supply Chains

GenScript Biotech Corporation, a global leader in life sciences research and manufacturing services, has officially joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner. This milesto...

Contract Services

16 January, 2025 | Thursday | News

Lyndra Partners with Thermo Fisher to Drive Phase 3 Trials and Commercial Manufacturing of Long-Acting Oral Therapies

Leveraging its Accelerator™ Drug Development, 360° CDMO and CMO solutions, Thermo Fisher will provide clinical research services for Lyndra’s phase 3 pivotal safety study for oral weekly r...

Consumer Health

06 January, 2025 | Monday | Analysis

Human Metapneumovirus Sparks Concern Across Asia: India Joins Global Vigilance

The detection of Human Metapneumovirus (HMPV) in Karnataka, India, and a rising number of cases across Asia have prompted heightened vigilance among health authorities. The Union Health Ministry of India confir...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close